Stem Cell Exosomes Reawaken Dormant Hair Follicles via Wnt Pathway Activation
hUCMSC-derived exosomes carrying miR-21-5p and let-7b-5p reverse androgenetic alopecia in mice by reigniting Wnt/β-catenin signaling in dermal papilla cells.
Summary
Researchers isolated exosomes from human umbilical cord mesenchymal stem cells (hUCMSCs) and tested them in a dihydrotestosterone (DHT)-induced androgenetic alopecia (AGA) mouse model. The exosomes promoted hair follicle enlargement and anagen-phase re-entry, while also boosting proliferation and migration of human dermal papilla cells (hDPCs) in vitro. Mechanistically, two highly enriched microRNAs within these exosomes—miR-21-5p and let-7b-5p—were found to target Cyclin D1, c-MET, and LEF1, collectively activating the Wnt/β-catenin signaling pathway. These findings position hUCMSC-derived exosomes as a promising cell-free regenerative therapy for hair loss, with a clearly defined molecular mechanism.
Detailed Summary
Androgenetic alopecia (AGA) affects hundreds of millions of people globally and is driven by DHT-induced follicular miniaturization and premature anagen-to-telogen cycling. Current treatments such as minoxidil and finasteride are modestly effective and carry side-effect burdens, creating demand for mechanistically distinct regenerative approaches. This study investigates whether exosomes secreted by hUCMSCs can reverse AGA-like hair follicle damage and elucidates the molecular pathways involved.
hUCMSCs were rigorously characterized by fluorescence-activated cell sorting, confirming high expression of mesenchymal markers (CD73, CD90, CD105 ≥95%) and low hematopoietic marker expression (CD45, CD34, CD14, HLA-DR, CD79a ≤2%). Exosomes were purified from fourth-passage conditioned media via sequential ultracentrifugation and confirmed by transmission electron microscopy, nanoparticle flow cytometry, and Western blot for canonical exosome markers (CD9, CD63, CD81, TSG101, Hsp70). A DHT-injected C57BL/6 mouse model was used for in vivo testing, with dorsal skin depilation followed by daily subcutaneous DHT administration. MSC-Exo were applied topically or injected, and outcomes assessed by transparent skin visualization, H&E staining, and immunofluorescence.
In vivo, MSC-Exo treatment significantly accelerated the telogen-to-anagen transition, enlarged follicle size, and restored hair shaft density compared to DHT-only controls. Histological analysis confirmed deeper, more mature follicle structures in the exosome-treated group. In vitro, hDPCs treated with MSC-Exo showed markedly increased proliferation (CCK-8 assay) and migration (scratch wound healing assay). The exosomes also shifted the secretory profile of hDPCs, upregulating pro-growth factors. MicroRNA profiling of the exosomes revealed high abundance of miR-21-5p and let-7b-5p. Mechanistic investigation showed these miRNAs target Cyclin D1, c-MET, and LEF1—upstream regulators of Wnt/β-catenin signaling—leading to pathway activation, increased β-catenin nuclear translocation, and enhanced hDPC functional differentiation. Western blot confirmed elevated β-catenin, c-MET, LEF1, and downstream targets including c-Myc and Cyclin D1 in treated cells.
These findings establish a coherent mechanistic axis: hUCMSC exosomes deliver miR-21-5p and let-7b-5p to dermal papilla cells, which activate Wnt/β-catenin signaling to drive follicular anagen re-entry and hair shaft regeneration. This is particularly notable because Wnt/β-catenin is a master regulator of hair follicle morphogenesis and cycling, and its suppression by DHT is central to AGA pathogenesis.
Caveats include the use of a DHT-injection mouse model, which approximates but does not fully replicate human AGA's genetic and hormonal complexity. The study does not include long-term follow-up data, dose-optimization experiments, or head-to-head comparisons with approved AGA therapies. The relative contributions of miR-21-5p versus let-7b-5p were not individually dissected, and cargo beyond microRNAs (proteins, lipids) in the exosomes was not fully characterized.
Key Findings
- MSC-Exo significantly promoted anagen-phase re-entry and follicle enlargement in DHT-induced AGA mice.
- hUCMSC exosomes boosted human dermal papilla cell proliferation and migration in vitro.
- Exosomes are highly enriched in miR-21-5p and let-7b-5p, two microRNAs targeting Cyclin D1, c-MET, and LEF1.
- These miRNAs activate Wnt/β-catenin signaling, the master pathway governing hair follicle growth cycling.
- hUCMSC-derived exosomes altered hDPC secretory profiles, suggesting paracrine amplification of hair-growth signals.
Methodology
Male C57BL/6 mice received daily DHT injections to model AGA; MSC-Exo were applied and outcomes assessed by H&E, immunofluorescence, and transparent skin imaging. In vitro experiments used CCK-8 and scratch wound assays on hDPCs. Exosomes were purified by ultracentrifugation and characterized by TEM, nanoparticle flow cytometry, and Western blot.
Study Limitations
The DHT-injection mouse model does not fully replicate human AGA's polygenic and hormonal complexity. Individual miRNA contributions were not separately validated, and no comparison with minoxidil or finasteride was performed. Long-term safety, dosing optimization, and full exosome cargo characterization remain to be addressed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.